The global protein expression market is expected to experience substantial growth in the coming years, projected to expand from $2.9 billion in 2022 to $5.4 billion by 2027 at a compound annual growth rate (CAGR) of 13.3%. This burgeoning market is driven by several key factors, including the increasing demand for protein biologics, particularly in the treatment of chronic diseases such as cancer, autoimmune disorders, and other serious conditions.
As the life science and biopharmaceutical industries continue to thrive, the focus on recombinant protein expression and the availability of investments for protein-based research are providing further impetus to the market’s growth. However, the high cost of protein expression reagents and instruments remains a restraining factor, potentially limiting adoption in certain areas.
Download a PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=180323924
One of the notable trends shaping the market is the emergence of microfluidics, an advanced technique offering robust solutions for protein expression studies and analysis. Microfluidic technologies, such as droplet-based microfluidic (DBM) high-throughput screening and microfluidic antibody capture (MAC) chips, are enabling more efficient and precise evaluation of protein expression levels and protein modifications.
While the market faces challenges related to undesired post-translational modifications and the complexities of protein purification, the mammalian cell expression system segment continues to dominate, driven by its low cost and ease of use.
Geographically, North America currently leads the protein expression market, propelled by the region’s strong biotechnology and pharmaceutical industries, the prevalence of chronic disorders, and increased investments in protein-based therapeutics research.
Key players in the global protein expression market include Thermo Fisher Scientific, Merck KGaA, GenScript Biotech Corporation, Agilent Technologies, Danaher Corporation, Sartorius AG, Takara Bio, Bio-Rad Laboratories, Lonza Group AG, Promega Corporation, New England Biolabs, and Oxford Expression Technologies Ltd.
As the demand for protein biologics continues to surge and technological advancements unlock new possibilities, the protein expression market is poised for sustained growth, driving innovation and propelling the development of groundbreaking therapeutics.
